Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

  1. Dalbeth, N.
  2. Jones, G.
  3. Terkeltaub, R.
  4. Khanna, D.
  5. Kopicko, J.
  6. Bhakta, N.
  7. Adler, S.
  8. Fung, M.
  9. Storgard, C.
  10. Baumgartner, S.
  11. Perez-Ruiz, F.
Aldizkaria:
Arthritis and Rheumatology

ISSN: 2326-5205,  2326-5191

Argitalpen urtea: 2017

Alea: 69

Zenbakia: 9

Orrialdeak: 1903-1913

Mota: Artikulua

DOI: 10.1002/ART.40159 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus